Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Leukeran

Leukeran
In stock
2mg · 5mg
from A$89.05
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$106.87A$89.05
A$8.91 per tablet

In brief

  • In our pharmacy you can buy leukeran without a prescription, with delivery available across Australia and discreet packaging on request.
  • Leukeran (chlorambucil) is used to treat chronic lymphocytic leukaemia (CLL), Hodgkin lymphoma and non‑Hodgkin lymphoma; it is an alkylating (nitrogen‑mustard) agent that cross‑links DNA and inhibits DNA replication in rapidly dividing cells.
  • Usual adult doses are typically 0.1–0.2 mg/kg/day orally (CLL/NHL) with maintenance often 2–8 mg/day; for Hodgkin lymphoma regimens around 0.2 mg/kg/day for 4–8 weeks or intermittent cycles are used—dosing must be individualised by a clinician.
  • Administered orally as a film‑coated tablet (commonly 2 mg tablets).
  • The drug begins to affect dividing cells within days, but meaningful clinical responses (reduced lymphocyte counts or tumour shrinkage) usually take several weeks.
  • There is no single “duration of action” for one dose—treatment is usually prolonged and cyclical over weeks to months, and the cytotoxic effects (including bone marrow suppression) can persist for days to weeks after dosing stops.
  • Avoid or limit alcohol while on leukeran as alcohol may worsen nausea, fatigue and liver stress and increase overall adverse effects; discuss with your prescriber or pharmacist.
  • The most common side effects are bone marrow suppression (leucopenia/neutropenia, anaemia, thrombocytopenia), plus nausea, vomiting, diarrhoea, mouth sores, rash and fatigue; there is also an increased infection risk and rare long‑term risks such as secondary malignancies and infertility.
  • Would you like to try leukeran without a prescription?

Basic Leukeran Information

  • INN (International Nonproprietary Name): Chlorambucil
  • Brand Names Available In Australia: Leukeran (international listings); other markets may list chloraminophene or generic chlorambucil (local Australian distributor / ARTG listing should be confirmed)
  • ATC Code: L01AA02 (Antineoplastic Agents — Alkylating Agents — Chlorambucil)
  • Forms & Dosages: Film-coated tablet, 2 mg orally administered
  • Manufacturers In Australia: Not specified (Aspen Pharmacare is a primary international supplier; verify local sponsor and packaging)
  • Registration Status In Australia: Not specified (verify ARTG entry and TGA medicine search prior to supply)
  • OTC / Rx Classification: Prescription-only medicine (Rx)

Critical Warnings & Restrictions

Are there immediate safety issues I should know before starting leukeran?

Chlorambucil is a cytotoxic alkylating agent and must be handled and used with safety as the top priority.

Confirm current TGA and PBS status locally before prescribing or dispensing and record this check in the patient file.

Obtain informed consent and document fertility and contraception counselling before treatment starts.

Baseline and regular monitoring of full blood count (FBC), liver function tests (LFTs) and renal function are mandatory before and during therapy.

Pregnant or breastfeeding people must not take chlorambucil; it is contraindicated in pregnancy and lactation.

Tablets are hazardous to handle; staff and patients should use gloves when handling and avoid crushing or splitting without pharmacy guidance.

Pharmacy practice note: record chemotherapy counselling and provide a written safety sheet to the patient that includes emergency contact details.

If severe bone marrow suppression or hypersensitivity is known, chlorambucil must not be used.

Safety-First Summary For Australian Patients

What immediate safety steps will my clinic and pharmacy take for me?

Confirm TGA/PBS status and who is the ARTG sponsor before supply.

Deliver clear informed consent and fertility counselling, and document contraception plans in the record.

Require baseline and ongoing blood tests — FBC, LFTs and renal function — with results reviewed prior to each dose change.

Provide a written safety sheet and record structured chemotherapy counselling in the pharmacy file.

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Who is at greatest risk of harm from leukeran?

Absolute contraindications include known hypersensitivity, severe bone-marrow suppression, pregnancy and breastfeeding.

Relative risk increases for the elderly due to greater myelosuppression and for people with liver or renal impairment.

Prior radiotherapy or chemotherapy, active infection and epilepsy raise the risk and require specialist oversight.

Use a pre-treatment checklist: baseline FBC, pregnancy test where applicable, clear contraception plan, documented fertility discussion and a full medication review.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Will chlorambucil affect my ability to work, drive or operate machinery?

Patients may experience fatigue, dizziness or be more prone to infection; these effects can affect driving and manual tasks.

Advise patients to avoid heavy machinery or driving if they feel dizzy, very tired or have neurological symptoms.

Discuss workplace disclosure with patients where manual handling or safety-sensitive roles exist and document advice in the patient record.

Q&A — “Can I Drive After Taking It In Australia?”

Usually driving is permitted if you are asymptomatic.

If you feel dizzy, very tired or experience neurological side effects, do not drive and seek medical advice.

Document the advice given in the patient record and remind patients to follow employer safety policies for safety‑sensitive work.

Usage Basics

What is leukeran and how is it labelled?

INN: Chlorambucil, most commonly known internationally as Leukeran in 2 mg tablet form.

Some markets list generics under the INN chlorambucil or alternate trade names; local Australian packaging and ARTG listing must be confirmed before supply.

INN, Brand Names Available In Australia

Which brand names should Australian clinicians expect to see on prescriptions?

Internationally Leukeran is the common brand name supplied as 2 mg tablets, with Aspen Pharmacare cited as a primary international supplier.

Local Australian brand or sponsor details are not specified in the raw data and should be checked on the ARTG before dispensing.

Legal Classification (TGA-Approved, PBS-Listed)

Is leukeran subsidised or prescription-only in Australia?

Chlorambucil/Leukeran is prescription‑only (Rx) in major territories according to the product data and must be dispensed on a valid prescription.

Check the Australian Register of Therapeutic Goods (ARTG) for current TGA approval and consult the PBS schedule for item numbers and subsidy eligibility.

Pharmacists should verify PBS item codes and authority requirements to maximise subsidies for eligible patients when dispensing.

  • Counselling Prompts: Confirm prescription and indication before supply.
  • Discuss the monitoring schedule and the need for regular blood tests.
  • Explain fertility risks and contraception requirements.
  • Advise infection precautions and safe handling of tablets.
  • Explain storage and what to do with missed doses or adverse effects.

Dosing Guide

How is leukeran typically dosed for common conditions?

Typical adult dosing is condition-dependent and tailored by a specialist according to response and blood counts.

Standard Regimens (PBS Reference Dosing)

For chronic lymphocytic leukaemia (CLL), the usual adult dosing is 0.1–0.2 mg/kg/day orally until white cell count falls, with maintenance often 2–8 mg/day.

For Hodgkin lymphoma, regimens around 0.2 mg/kg/day for 4–8 weeks or intermittent cycles have been used.

For non‑Hodgkin lymphoma, dosing is commonly 0.1–0.2 mg/kg/day or given as cyclical regimens.

Tablets come as film-coated 2 mg units and treatment tends to be prolonged and adjusted by response and blood counts.

Adjustments For Comorbidities

What dose changes are needed for older adults or organ impairment?

Elderly patients should start at lower doses with close FBC monitoring for myelosuppression.

Liver or kidney impairment merits dose reduction and closer monitoring, particularly where liver dysfunction exists.

Paediatric use is not well established and should be managed only by paediatric oncology specialists.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is close to the next scheduled dose.

Do not double up doses to make up for a missed one.

When in doubt, contact the specialist clinic or pharmacy and document missed doses in the patient record.

  • Monitoring Checklist: Baseline FBC, LFTs, renal function.
  • Weekly blood tests initially, then per specialist plan and response.
  • Pregnancy test as indicated and infection vigilance throughout treatment.

Interaction Chart

Which foods, drinks and medicines interact with leukeran?

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

No specific pharmacokinetic food restrictions are listed for chlorambucil in the raw data, but alcohol can worsen nausea and affect liver function tests during therapy.

Advise moderation of alcohol while taking chlorambucil and monitoring of LFTs.

No major food restrictions are required, but emphasise safe food handling to reduce infection risk in patients with immunosuppression.

Common Drug Conflicts

What drug combinations raise concern?

Concurrent myelosuppressive drugs, including other chemotherapies or certain antibiotics, can add haematologic toxicity and require dose adjustments.

Live vaccines are contraindicated during immunosuppression with chlorambucil.

As an alkylating agent (ATC L01AA02), interactions are often additive toxicity rather than classic CYP-mediated effects, so complete medication review is essential.

Drug Interaction Type Clinical Action
Bendamustine Additive Myelosuppression Avoid combination unless specialist-managed; monitor FBC closely
Cyclophosphamide Additive Haematologic Toxicity Specialist-led regimens and frequent blood monitoring
Fludarabine Increased Immunosuppression Assess infection risk and adjust dosing with haematologist
Ibrutinib / Venetoclax Potential Overlap In Effects; Different Mechanisms Specialist review; consider targeted therapy benefits vs risks
  • Always review OTC medicines and complementary medicines for interaction risk.
  • Avoid live vaccines while immunosuppressed and until immune recovery is confirmed.

User Reports & Trends

What are patients saying about leukeran in Australia?

Online feedback and forum posts commonly mention the side-effect burden such as fatigue, nausea and low blood counts.

Cost concerns and the need for clear pharmacy counselling are frequent themes in patient reviews.

Many patients value the oral convenience of older agents like chlorambucil, while noting that newer targeted therapies have displaced it in many cases.

  • Collect patient-experienced side-effects and their severity.
  • Identify adherence barriers such as nausea, complexity of monitoring and cost.
  • Measure satisfaction with pharmacy support, written counselling and telehealth follow-up.

Caveats: online reviews are anecdotal and can be biased; clinical decisions must rely on oncology guidance and evidence rather than individual reports.

  1. Pros: Oral route, familiar long-term data, lower direct drug cost in some settings.
  2. Cons: Significant myelosuppression risk, fertility concerns, and often less effectiveness than many modern targeted agents for certain indications.

Access & Purchase Options

How can patients in Australia obtain leukeran safely and legally?

Large national chains and hospital outpatient pharmacies commonly dispense chemotherapy prescriptions where handling protocols exist.

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Community pharmacies may dispense cytotoxic tablets when they have appropriate handling protocols and supply agreements with the prescriber or hospital.

Always confirm stock and PBS subsidised scripts where applicable prior to patient presentation.

Online Pharmacies And Telehealth E-Prescriptions

E-prescriptions issued by an authorised clinician are accepted, provided the prescription is authentic and matches the ARTG product supplied.

Use accredited online pharmacies and avoid illicit sellers; for rural patients, allow time for pharmacies to order stock or consider hospital pharmacy options.

In our online pharmacy, leukeran is available with discreet delivery to Australia in 9–21 days.

  • Checklist For Safe Purchase: valid specialist prescription; ARTG/PBS verification; confirm brand/INN and packaging; pharmacy offers cytotoxic counselling and safe disposal advice.
Access Route Typical Wait Time PBS Subsidy
Hospital Outpatient Chemotherapy Unit 1–7 days Often eligible depending on indication and authority
Community Pharmacy (In-Store) 1–7 days (may order) Check PBS item number
Accredited Online Pharmacy 9–21 days Varies; verify PBS before ordering

Mechanism & Pharmacology

How does leukeran work against cancer cells?

Chlorambucil is an alkylating agent that adds alkyl groups to DNA, causing crosslinking and preventing cancer cell replication.

It is cell-cycle non‑specific and predominantly affects rapidly dividing lymphoid cells, which explains its use in CLL and some lymphomas.

Oral 2 mg film-coated tablets permit outpatient administration for eligible patients.

Clinical Terms (Brief Glossary)

Alkylating Agent: Damages DNA to prevent cell replication and cause cell death.

Myelosuppression: Decreased bone-marrow production of blood cells, leading to anaemia, neutropenia or thrombocytopenia.

Maintenance Dosing: Lower ongoing doses given to control disease over time.

Pharmacology Clinical Effect
DNA Crosslinking Leads To Cancer Cell Death
Cell-Cycle Non-Specific Action Broad Activity Against Dividing Cells

Safety Note: The DNA‑damaging mechanism explains risks such as infertility and rare secondary malignancies; fertility counselling prior to treatment is essential.

Indications & Off-Label Uses

What conditions is leukeran approved to treat?

Internationally, chlorambucil is indicated for chronic lymphocytic leukaemia (CLL), Hodgkin lymphoma and non‑Hodgkin lymphoma including follicular types.

Australian TGA-approved indications and PBS listings should be verified for local use and subsidy eligibility prior to prescribing.

Approved Indications By TGA

Check the ARTG and current TGA product information for precise approved indications and sponsor details in Australia.

Where PBS coverage applies, authority criteria and item numbers determine subsidy availability.

Off-Label Uses In Australian Clinical Practice

Off‑label use of chlorambucil should be specialist-led with a documented clinical rationale and informed consent.

Historically it has been used in indolent lymphoproliferative disorders for palliative control where oral therapy or cost considerations applied.

With modern targeted agents, off‑label use is less common but may persist in resource-limited settings or specific clinical scenarios.

  • Approved: CLL, Hodgkin lymphoma, selected NHL subtypes (verify TGA).
  • Potential Off‑Label: Indolent lymphoproliferative disorders or palliative regimens where indicated by specialist.
  • Checklist For Documentation: specialist rationale, informed patient consent, monitoring plan recorded.

Key Clinical Findings

What does the clinical evidence say about leukeran?

Chlorambucil is an established cytotoxic with decades of data showing responses in indolent lymphoid malignancies.

It can induce remissions in CLL and some indolent lymphomas but carries significant haematologic toxicity risk including neutropenia, anaemia and thrombocytopenia.

Long‑term concerns include infertility and rare secondary malignancies, which should be discussed prior to treatment.

Recent practice up to mid‑2024 trends towards targeted oral agents such as ibrutinib and venetoclax for many CLL settings, with chlorambucil used selectively when newer agents are unsuitable.

  • Effective in inducing responses in CLL and some indolent lymphomas.
  • Associated with meaningful haematologic toxicity that requires monitoring.
  • Long-term risks include infertility and rare secondary cancers.

Research Note: Clinicians should consult the latest guideline updates from Australian cancer networks and haematology societies for trial evidence and 2022–2024 guidance; check for newer updates beyond that timeframe.

Alternatives Matrix

What are the main alternatives to leukeran and how do they compare?

Competing agents include bendamustine, cyclophosphamide, fludarabine and newer targeted agents such as ibrutinib and venetoclax.

PBS-Listed Alternatives Comparison Table

Drug Class Route Typical Use PBS Status
Bendamustine Alkylating Agent Intravenous CLL, NHL Often PBS-listed with authority criteria
Cyclophosphamide Alkylating Agent Oral/IV Various lymphoid malignancies PBS-listed for many regimens
Ibrutinib BTK Inhibitor Oral CLL PBS-listed with strict criteria
Venetoclax BCL-2 Inhibitor Oral CLL PBS-listed with authority requirements

Pros And Cons Checklist

  • Chlorambucil: Oral and low direct drug cost in some settings; cons include myelosuppression, fertility risk and often lower efficacy than some targeted agents.
  • Bendamustine/Cyclophosphamide: Parenteral options with different toxicity profiles and distinct monitoring needs.
  • Ibrutinib/Venetoclax: Targeted therapies often delivering superior outcomes in many CLL settings but are higher cost and have specific PBS coverage rules.

Decision Support: Map patient factors such as age, comorbidity, fertility desires, PBS eligibility and geographic access to the most suitable treatment with specialist input.

Common Questions

What do patients ask most often about leukeran, and what should the pharmacy leaflet say?

  • How Is Leukeran Taken?: Oral tablets taken exactly as prescribed by the specialist; follow the dosing schedule and monitoring plan.
  • What Tests Will I Need?: Baseline and regular FBC, LFTs and renal function; frequency determined by the treating specialist.
  • Will It Make Me Sterile?: There is a risk of irreversible infertility; discuss fertility preservation options before treatment begins.
  • Can I Have Vaccines?: Avoid live vaccines during treatment and until immune recovery; check timing with the specialist.
  • What Are Warning Signs?: Fever, bleeding, severe bruising or persistent vomiting require urgent medical review or attendance at emergency/oncology clinic.

Action Steps For Each FAQ: Fever = stop medication and seek urgent care; heavy bleeding = immediate ED; missed dose = contact pharmacy or clinic for advice.

Mini-Checklist For Appointments: bring current medication list, contraception plan, recent blood-test results and the written safety sheet provided by pharmacy.

Price & Access Comparison Table

How much will leukeran cost and where can I source it in Australia?

Source Typical Cost (Unsubsidised) PBS Subsidy Availability Wait Time Notes
Community Pharmacy (In-Store) Varies Check PBS item number 1–7 days Confirm cytotoxic handling and counselling
Hospital Outpatient Chemotherapy Unit Typically subsidised per public hospital policy Often eligible depending on indication 1–7 days Specialist dispensing and monitoring
Accredited Online Pharmacy Varies; shipping costs apply Varies; verify PBS before ordering 9–21 days Ensure ARTG product match and accredited seller
  • Access Checklist: verify prescription and PBS authority number, call ahead to confirm stock at major chains, and confirm the pharmacy provides cytotoxic counselling and disposal advice.
  • Rural vs Urban: rural patients should allow extra ordering time and consider hospital pharmacy collection if urgent.

Registration & Regulation

How do Australian registration and subsidy systems affect supply of leukeran?

Confirm the ARTG entry and sponsor details using the TGA medicine search before supply or ordering.

Chlorambucil is prescription-only; pharmacists must supply under Schedule 4/Rx rules and follow state and national dispensing regulations.

TGA Approval

Use the TGA’s online search to verify ARTG numbers, product information and sponsor details before dispensing.

Local ARTG entries and sponsor names are not specified in the raw data and must be verified at point of supply.

PBS Subsidy Details

PBS coverage varies by indication, formulation and authority criteria; confirm current item numbers and eligibility on the PBS schedules.

Document any PBS authority approvals and retain copies in the patient record where required.

Step-By-Step For Clinicians: search TGA ARTG database for product, check PBS item listing and authority criteria, and record evidence of subsidy eligibility in the patient record.

Storage & Handling

How should leukeran be stored at home and in pharmacy given Australian climate concerns?

Household Storage In Australian Climate (Heat/Humidity)

Store chlorambucil at 20–25°C and protect it from light and moisture, avoiding temperatures above 30°C.

Advise patients to keep tablets in the original container in a cool, dry place away from bathrooms and direct sunlight.

If travelling, suggest hand luggage or an insulated pack to avoid prolonged heat exposure on hot Australian days.

Cold‑Chain Handling For Pharmacies

Chlorambucil tablets are not cold chain products, but maintain controlled room temperature during storage and transport.

Pharmacy staff must use gloves when dispensing cytotoxic tablets and advise patients not to crush tablets; splitting should occur only under pharmacy protocol.

Return unused tablets to the pharmacy for safe disposal and do not discard in household rubbish.

Item Temperature Range Transport Note
Storage 20–25°C (avoid >30°C) Keep in original container, protect from moisture and light
Transport Controlled Room Temperature Avoid prolonged heat during postal transit; use insulated packaging if required
  • Safe Disposal: return unused or expired tablets to a pharmacy for cytotoxic waste disposal.

Guidelines For Proper Use

What should pharmacy counselling include when dispensing leukeran?

Australian Pharmacist Counselling Style

Counselling should confirm the indication and dosing schedule and clearly explain side effects with action thresholds for fever, bleeding or severe vomiting.

Discuss contraception and fertility risks and confirm plans for pregnancy avoidance and fertility preservation where relevant.

Provide a written summary of the monitoring schedule and local support contacts and ensure the patient understands when to seek urgent care.

Patient Advice From PBS And National Health Authorities

Follow PBS and TGA guidance and state oncology resources for standardised patient advice points on contraception, infection precautions and monitoring.

Key advice includes avoiding pregnancy, promptly reporting fever or bleeding, attending scheduled blood tests and storing medication safely.

For financial or access concerns, refer patients to social work, patient assistance programs or the treating hospital’s pharmacy support services.

  • Discharge Counselling Checklist: medication list, blood-test schedule, fertility counselling documentation, written safety sheet and emergency contact numbers.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Hobart Tasmania 9-14 days
Canberra Australian Capital Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 14-21 days
Geelong Victoria 14-21 days
Townsville Queensland 14-21 days
Ballarat Victoria 14-21 days
Bendigo Victoria 14-21 days
Albury New South Wales 14-21 days

Related products